<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ASND
Ascendis Pharma
$
()


  • Ascendis Pharma price target raised by $18 at Wedbush, here's why

    2/8/2024 - 07:48am
  • Ascendis Pharma price target raised by $36 at Citi, here's why

    2/8/2024 - 06:39am
  • Ascendis Pharma announces formation, launch with Frazier Life of Eyconis

    1/29/2024 - 08:47am
  • Ascendis Pharma price target raised by $23 at TD Cowen, here's why

    1/10/2024 - 07:34am
  • Ascendis Pharma, Vector Pharma FZCO enter exclusive distribution agreement

    1/8/2024 - 08:39am
  • Specialised Therapeutics signs exclusive agreement with Ascendis Pharma

    1/7/2024 - 14:01pm
  • Ascendis Pharma announces new analyses from OLE portions of ACcomplisH

    12/20/2023 - 08:33am
  • Ascendis Pharma price target raised by $2 at Wedbush, here's why

    12/20/2023 - 08:12am
  • Ascendis Pharma price target raised by $23 at TD Cowen, here's why

    12/20/2023 - 07:28am
  • Ascendis Pharma price target raised by $5 at BofA, here's why

    12/20/2023 - 06:57am
  • Ascendis Pharma initiated with bullish view at Jefferies, here's why

    12/20/2023 - 05:35am
  • Ascendis Pharma price target raised by $5 at BofA, here's why

    12/19/2023 - 20:13pm
  • Ascendis announces TransCon hGH achieved 'statistically superior' outcomes

    12/19/2023 - 08:39am
  • Oppenheimer, Wedbush say buy these biotech stocks for 2024

    12/14/2023 - 13:31pm
  • Ascendis Pharma announces FDA acceptance of resubmitted TransCon PTH NDA

    12/11/2023 - 08:39am
dynamic_feed Breaking News